Gene · 81608
Papers2,072
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,072
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nudt21-mediated alternative polyadenylation of MZT1 3'UTR contributes to pancreatic cancer progression. | iScience | 2024 | 38303721 | PubTator, text mining | PubMed |
| Prognostic DNA mutation and mRNA expression analysis of perineural invasion in oral squamous cell carcinoma. | Sci Rep | 2024 | 38287071 | PubTator, text mining | PubMed |
| Cell-Free DNA and Next-Generation Sequencing for Prenatal Diagnosis. | Methods Mol Biol | 2024 | 38285369 | PubTator, text mining | PubMed |
| Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment. | Genes (Basel) | 2024 | 38275618 | PubTator, text mining | PubMed |
| A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma. | Biomedicines | 2024 | 38255303 | PubTator, text mining | PubMed |
| Toxocarosis in a patient with autism spectrum disorder presenting with severe hypereosinophilia and acute respiratory distress: a case report. | Parasitol Res | 2024 | 38228848 | PubTator, text mining | PubMed |
| The application of approaches in detecting ferroptosis. | Heliyon | 2024 | 38187349 | PubTator, text mining | PubMed |
| Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report. | Ann Hematol | 2024 | 37777636 | PubTator, text mining | PubMed |
| Application of blood group genotyping in complex cases of immunohematology. | Asian J Transfus Sci | 2023 | 38274970 | PubTator, text mining | PubMed |
| The "Big Three" in biocompatibility testing of medical devices: implementation of alternatives to animal experimentation-are we there yet? | Front Toxicol | 2023 | 38259728 | PubTator, text mining | PubMed |
| Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases. | Front Immunol | 2023 | 38250075 | PubTator, text mining | PubMed |
| Neutrophilic and eosinophilic dermatoses associated with hematological malignancy. | Front Med (Lausanne) | 2023 | 38249974 | PubTator, text mining | PubMed |
| A Rare Case of Isolated Right Ventricular Loeffler's Endocarditis in Primary Hypereosinophilic Syndrome. | J Cardiovasc Echogr | 2023 | 38161771 | PubTator, text mining | PubMed |
| Liver Dysfunction with Severe Cholestasis and Coagulation Disorders in the Course of Hemolytic Disease of the Newborn Requiring Chelation Therapy-A Case Report and Review of the Literature. | J Clin Med | 2023 | 38137714 | PubTator, text mining | PubMed |
| Retrospective Analysis of 397 Dermatoses Inpatients Associated with Blood Eosinophilia. | Clin Cosmet Investig Dermatol | 2023 | 38077918 | PubTator, text mining | PubMed |
| Effect of RhD and RhE sample phenotypic blood transfusion on the prognosis of hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 38065917 | PubTator, text mining | PubMed |
| Small but strong: the emerging role of small nucleolar RNA in cardiovascular diseases. | Front Cell Dev Biol | 2023 | 38033868 | PubTator, text mining | PubMed |
| Photoelectrocatalytic Surfactant Pollutant Degradation and Simultaneous Green Hydrogen Generation. | Ind Eng Chem Res | 2023 | 38020790 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer. | Sci Adv | 2023 | 37992178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81608/papers?page=5